CountriesCanada

Products 1 to 10 of 26

Biotech components: Bacteria
Business models: B2B
Country of production: USA
Country of distribution: USA + Sweden + Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Venture Capital
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
AquAdvantage Salmon (#1) by AquaBounty
Biotech components: Animal
Business models: B2C
Country of production: USA + Canada
Country of distribution: USA + Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 28,300,000 USD
Funding types: Private Funding + Venture Capital
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Private Company
Product categories: Food
Production process: Open Release
Source: Web search
Trading symbol: AQB (NASDAQ)
Value chain stage: Finished Product
AquAdvantage Salmon (#2) by AquaBounty
Biotech components: Animal
Business models: B2C
Country of production: USA
Country of distribution: USA + Canada
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/09/06 10:13 (6 years ago)
Known funding amount: 38,000,000 USD
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Public Company
Product categories: Food
Production process: Open Release
Source: NASEM Database
Trading symbol: AQB (NASDAQ)
Value chain stage: Finished Product
Arctic Apple by Okanagan Specialty Fruits + Intrexon
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA + Canada
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/02 15:47 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Public Company
Product categories: Food
Production process: Open Release
Source: NASEM Database
Trading symbol: XON (NYSE)
Value chain stage: Finished Product
Bio-based 1,4 Butanediol by BioAmber, Inc.
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:28 (6 years ago)
Known funding amount: 3,000,000 CAN
Funding types: Debtor-in-possession financing + Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: NASEM Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
Bio-based Disodium Succinate by BioAmber, Inc.
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:28 (6 years ago)
Known funding amount: 3,000,000 CAN
Funding types: Debtor-in-possession financing + Shareholder Investment
Industry: Food & Agriculture
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Additive
Production process: Closed Production
Source: NASEM Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
Biotech components: Plant
Business models: B2B
Country of production: Canada
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:28 (6 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
Biotech components: Plant
Business models: B2C
Country of production: Canada
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:29 (6 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Personal Care
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Finished Product
BIO-SA Based Polyurethanes by BioAmber, Inc.
Biotech components: Plant
Business models: B2B
Country of production: Canada
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:29 (6 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
BIO-SA Based Resins & Coatings by BioAmber, Inc.
Biotech components: Plant
Business models: B2C
Country of production: Canada
Country of distribution: Benelux + France + Iberia + Germany + Poland + Switzerland + UK + Ireland
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:30 (6 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Finished Product